Published ahead of print on December 30, 2004, doi:10.1165/rcmb.2004-0197OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 32, pp. 201-210, 2005
© 2005 American Thoracic Society DOI: 10.1165/rcmb.2004-0197OC
Mycoplasma pneumoniae Induces Host-Dependent Pulmonary Inflammation and Airway Obstruction in Mice
Monica Fonseca-Aten,
Ana M. Ríos,
Asunción Mejías,
Susana Chávez-Bueno,
Kathy Katz,
Ana M. Gómez,
George H. McCracken, Jr. and
R. Doug Hardy
Departments of Pediatrics, Internal Medicine, and Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
Correspondence and requests for reprints should be addressed to Monica Fonseca-Aten, M.D, Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9063. E-mail address: Monica.Fonseca-Aten{at}utsouthwestern.edu
Respiratory tract infections result in wheezing in a subset of patients. Mycoplasma pneumoniae is a common etiologic agent of acute respiratory infection in children and adults that has been associated with wheezing in 2040% of individuals. The current study was undertaken to elucidate the host-dependent pulmonary and immunologic response to M. pneumoniae respiratory infection by studying mice with different immunogenetic backgrounds (BALB/c mice versus C57BL/6 mice). After M. pneumoniae infection, only BALB/c mice developed significant airway obstruction (AO) compared with controls. M. pneumoniaeinfected BALB/c mice manifested significantly elevated airway hyperresponsiveness (AHR) compared with C57BL/6 mice 4 and 7 d after inoculation as well as BALB/c control mice. Compared with C57BL/6 mice, BALB/c mice developed worse pulmonary inflammation, including greater peribronchial infiltrates. Infected BALB/c mice had significantly higher concentrations of tumor necrosis factor- , interferon- , interleukin (IL)-1ß, IL-6, IL-12, KC (functional IL-8), and macrophage inflammatory protein 1 in the bronchoalveolar lavage fluid compared with infected C57BL/6 mice. No differences in IL-2, IL-4, IL-5, IL-10, and granulocyte/macrophage colony-stimulating factor concentrations were found. The mice in this study exhibited host-dependent infection-related AO and AHR associated with chemokine and T-helper type (Th)1 pulmonary host response and not Th2 response after M. pneumoniae infection.
Key Words: Mycoplasma pneumoniae airway obstruction asthma airway hyperresponsiveness cytokines chemokines
This article has been cited by other articles:

|
 |

|
 |
 
K. Chmura, X. Bai, M. Nakamura, P. Kandasamy, M. McGibney, K. Kuronuma, H. Mitsuzawa, D. R. Voelker, and E. D. Chan
Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells
Am J Physiol Lung Cell Mol Physiol,
July 1, 2008;
295(1):
L220 - L230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Salvatore, M. Fonseca-Aten, K. Katz-Gaynor, A. M. Gomez, and R. D. Hardy
Intranasal Interleukin-12 Therapy Inhibits Mycoplasma pneumoniae Clearance and Sustains Airway Obstruction in Murine Pneumonia
Infect. Immun.,
February 1, 2008;
76(2):
732 - 738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Miyashita, Y. Obase, K. Ouchi, K. Kawasaki, Y. Kawai, Y. Kobashi, and M. Oka
Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit
J. Med. Microbiol.,
December 1, 2007;
56(12):
1625 - 1629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Salvatore, M. Fonseca-Aten, K. Katz-Gaynor, A. M. Gomez, A. Mejias, C. Somers, S. Chavez-Bueno, G. H. McCracken, and R. D. Hardy
Respiratory Tract Infection with Mycoplasma pneumoniae in Interleukin-12 Knockout Mice Results in Improved Bacterial Clearance and Reduced Pulmonary Inflammation
Infect. Immun.,
January 1, 2007;
75(1):
236 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Stelmach, M. Podsiadlowicz-Borzecka, T. Grzelewski, P. Majak, W. Stelmach, J. Jerzynska, M. Poplawska, and J. Dziadek
Humoral and Cellular Immunity in Children with Mycoplasma pneumoniae Infection: a 1-Year Prospective Study
Clin. Vaccine Immunol.,
October 1, 2005;
12(10):
1246 - 1250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Rios, M. Fonseca-Aten, A. Mejias, S. Chavez-Bueno, K. Katz, A. M. Gomez, G. H. McCracken Jr., O. Ramilo, and R. D. Hardy
Microbiologic and Immunologic Evaluation of a Single High Dose of Azithromycin for Treatment of Experimental Mycoplasma pneumoniae Pneumonia
Antimicrob. Agents Chemother.,
September 1, 2005;
49(9):
3970 - 3973.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society.
|
|
|